endocrine system
Learn MoreOur innovative circulatory system Cas9 Cell Lines offer a cutting-edge solution for targeted genetic modifications within the cardiovascular system Utilizing the transformative CRISPR technology these cell lines provide a precise and efficient method for studying and manipulating genes related to heart health and circulation opening new possibilities for cardiovascular research and therapy development
Catalog Number | Product Name | Species | System | Price |
---|
The circulatory system Cas9 Cell Lines offer a cutting-edge tool for precision genetic editing within living organisms enabling targeted modifications to genes involved in circulatory system function This technology holds promise for developing novel therapies for cardiovascular diseases and advancing our understanding of circulatory system biology at a cellular level paving the way for innovative medical interventions and treatments
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.